Drug Profile
SB 234551
Alternative Names: 234551Latest Information Update: 11 May 2007
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Renal failure; Stroke